The 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology and Clinical Applications will take place November 12–16, 2011, at the Moscone Center West in San Francisco. This major conference brings together more than 3,000 academics, scientists and representatives from the pharmaceutical industry to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.
This year’s program features eight plenary sessions that highlight the latest high-impact research in cancer therapeutics. To provide attendees with supporting information for these sessions, we have compiled a list of AACR journal articles relating to the plenary session topics. Access to the abstract of each article is FREE.
Chairperson: José Baselga, Massachusetts General Hospital Cancer Center, Boston, MA
Sunday, November 13, 10:30 a.m.–12:30 p.m.
Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY
Sunday, November 13, 2:30 p.m.–4:30 p.m.
Chairperson: Emma M. Lees, Novartis Institutes for BioMedical Research, Emeryville, CA
Monday, November 14, 8:00 a.m.–10:00 a.m.
Chairperson: Cornelis J.M. Melief, Leiden University Medical Center, Leiden, The Netherlands
Monday, November 14, 10:30 a.m.–12:30 p.m.
Chairperson: Robert Brown, Imperial College London, London, United Kingdom
Tuesday, November 15, 8:00 a.m.–10:00 a.m.
Chairperson: Nadia Harbeck, University Hospital of Cologne, Cologne, Germany
Tuesday, November 15, 10:30 a.m.–12:30 p.m.
Chairperson: Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Wednesday, November 16, 8:00 a.m.–10:00 a.m.
Chairperson: Christian Dittrich, Ludwig Boltzmann Institute for Applied Cancer Research, Vienna, Austria
Wednesday, November 16, 10:30 a.m.–12:30 p.m.
Further information:
2011 Molecular Targets and Cancer Therapeutics